Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Life Science History - Page 40

Life Science History

Innovation Pharma’s Brilacidin for the treatment of COVID-19 received FDA Fast Track Designation
COVID-19 | FDA | Life Science History

Innovation Pharma’s Brilacidin for the treatment of COVID-19 received FDA Fast Track Designation

On Jan. 14, 2021, Innovation Pharmaceuticals announced that the FDA had designated as a Fast Track development program…

Read More Innovation Pharma’s Brilacidin for the treatment of COVID-19 received FDA Fast Track DesignationContinue

PerkinElmer SARS-CoV-2 RT-PCR assay received FDA EUA for asymptomatic testing
COVID-19 | FDA | Life Science History

PerkinElmer SARS-CoV-2 RT-PCR assay received FDA EUA for asymptomatic testing

On Jan. 14, 2021, PerkinElmer announced that its PerkinElmerᆴ Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization…

Read More PerkinElmer SARS-CoV-2 RT-PCR assay received FDA EUA for asymptomatic testingContinue

COVID-19 reduced US life expectancy, especially among Black and Latino populations
COVID-19 | Life Science History

COVID-19 reduced US life expectancy, especially among Black and Latino populations

On Jan. 14, 2021, USC and Princeton researchers reported that the COVID-19 pandemic, which claimed more than 336,000…

Read More COVID-19 reduced US life expectancy, especially among Black and Latino populationsContinue

Cepheid received Health Canada license for SARS-CoV-2, Flu A, Flu B and RSV combination test
COVID-19 | Life Science History

Cepheid received Health Canada license for SARS-CoV-2, Flu A, Flu B and RSV combination test

On Jan. 14, 2021, Cepheid that Health Canada announced that it had issued Cepheid a medical device license…

Read More Cepheid received Health Canada license for SARS-CoV-2, Flu A, Flu B and RSV combination testContinue

Oxford Immunotec’s T-SPOT SARS-CoV-2 test used to measure efficacy of Valneva’s COVID-19 vaccine candidate
Biotechnology | COVID-19 | Life Science History | Vaccine

Oxford Immunotec’s T-SPOT SARS-CoV-2 test used to measure efficacy of Valneva’s COVID-19 vaccine candidate

On Jan. 13, 2021, Oxford Immunotec announced the start of a collaboration with Valneva whereby it will perform…

Read More Oxford Immunotec’s T-SPOT SARS-CoV-2 test used to measure efficacy of Valneva’s COVID-19 vaccine candidateContinue

The USDA confirmed COVID-19 in gorillas at San Diego Zoo Safari Park
COVID-19 | Life Science History | USDA | Veterinary

The USDA confirmed COVID-19 in gorillas at San Diego Zoo Safari Park

On Jan. 13, 2021, the USDAメs (USDA) National Veterinary Services Laboratories announced confirmation of SARS-CoV-2 (the virus that…

Read More The USDA confirmed COVID-19 in gorillas at San Diego Zoo Safari ParkContinue

Alexion updated phase 3 study of ULTOMIRISᆴ (ravulizumab-cwvz) in hospitalized patients with COVID-19
COVID-19 | Life Science History

Alexion updated phase 3 study of ULTOMIRISᆴ (ravulizumab-cwvz) in hospitalized patients with COVID-19

On Jan. 13, 2021, Alexion announced the decision to pause further enrollment in the global Phase 3 study…

Read More Alexion updated phase 3 study of ULTOMIRISᆴ (ravulizumab-cwvz) in hospitalized patients with COVID-19Continue

FDA accepted for Priority Review the BLA for V114, Merckメs investigational 15-valent pneumococcal conjugate vaccine
FDA | Life Science History

FDA accepted for Priority Review the BLA for V114, Merckメs investigational 15-valent pneumococcal conjugate vaccine

On Jan. 12, 2021, Merck announced the FDA accepted for priority review a Biologics License Application (BLA) for…

Read More FDA accepted for Priority Review the BLA for V114, Merckメs investigational 15-valent pneumococcal conjugate vaccineContinue

Abbott announced fulfillment of Federal government purchase of 150 million BinaxNOWル COVID-19 Rapid Tests
FDA | Life Science History

Abbott announced fulfillment of Federal government purchase of 150 million BinaxNOWル COVID-19 Rapid Tests

On Jan. 12, 2021, Abbott announced it had received FDA 510(k) clearance for the first rapid handheld traumatic…

Read More Abbott announced fulfillment of Federal government purchase of 150 million BinaxNOWル COVID-19 Rapid TestsContinue

Global scientists doubled down on SARS-CoV-2 variants research
COVID-19 | Life Science History | WHO

Global scientists doubled down on SARS-CoV-2 variants research

On Jan. 12, 2021, the WHO announced that global scientists were intensifying research into COVID-19 to expand its…

Read More Global scientists doubled down on SARS-CoV-2 variants researchContinue

UC Berkeley scientists mapped coronavirus protein linked to disease severity
HIV | Life Science History

UC Berkeley scientists mapped coronavirus protein linked to disease severity

On Jan. 12, 2021, UC Berkeley HIV researchers announced that they had determined the atomic structure of a…

Read More UC Berkeley scientists mapped coronavirus protein linked to disease severityContinue

Regeneron announced US Government sgreement to purchase additional COVID-19 antibody cocktail doses
COVID-19 | Life Science History

Regeneron announced US Government sgreement to purchase additional COVID-19 antibody cocktail doses

On Jan. 12, 2021, Regeneron announced that the U.S. Department of Health and Human Services (HHS) and the…

Read More Regeneron announced US Government sgreement to purchase additional COVID-19 antibody cocktail dosesContinue

CureVac’s COVID-19 caccine aandidate, CVnCoV, demonstrated efficient protection of non-human primates
COVID-19 | Life Science History | Vaccine

CureVac’s COVID-19 caccine aandidate, CVnCoV, demonstrated efficient protection of non-human primates

On Jan. 11, 2021, CureVac announced the publication of preclinical data demonstrating the induction of robust antibody and…

Read More CureVac’s COVID-19 caccine aandidate, CVnCoV, demonstrated efficient protection of non-human primatesContinue

Abbott received CE Mark for its COVID-19 IgG quantitative antibody blood test
FDA | Life Science History

Abbott received CE Mark for its COVID-19 IgG quantitative antibody blood test

On Jan. 11, 2021, Abbott announced it had received FDA 510(k) clearance for the first rapid handheld traumatic…

Read More Abbott received CE Mark for its COVID-19 IgG quantitative antibody blood testContinue

FDA conditionally approved first oral tablet to treat lymphoma in dogs
FDA | Life Science History

FDA conditionally approved first oral tablet to treat lymphoma in dogs

On Jan. 11, 2021, the FDA conditionally approved Anivive Lifesciences’ Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma,…

Read More FDA conditionally approved first oral tablet to treat lymphoma in dogsContinue

Humanigen announced CRADA agreement with US government to develop lenzilumab for COVID-19
COVID-19 | FDA | Life Science History

Humanigen announced CRADA agreement with US government to develop lenzilumab for COVID-19

On Jan. 10, 2021, Humanigen announced that they were partnering to make lenzilumab available to hospitalized and hypoxic…

Read More Humanigen announced CRADA agreement with US government to develop lenzilumab for COVID-19Continue

FDA issued alert regarding SARS-CoV-2 viral mutation to health care providers and clinical laboratory staff
FDA | Genomics | Life Science History

FDA issued alert regarding SARS-CoV-2 viral mutation to health care providers and clinical laboratory staff

On Jan. 8, 2021, the FDA alerted clinical laboratory staff and health care providers that it was monitoring…

Read More FDA issued alert regarding SARS-CoV-2 viral mutation to health care providers and clinical laboratory staffContinue

PerkinElmer announced the acquisition of Oxford Immunotec for $591 million in cash
Life Science History

PerkinElmer announced the acquisition of Oxford Immunotec for $591 million in cash

On Jan. 7, 2021, PerkinElmer and Oxford Immunotec announce an agreement under which PerkinElmer acquired Oxford Immunotec for…

Read More PerkinElmer announced the acquisition of Oxford Immunotec for $591 million in cashContinue

Oragenics entered into material transfer agreement with adjuvance technologies for COVID-19 vaccine adjuvant
COVID-19 | Life Science History | Vaccine

Oragenics entered into material transfer agreement with adjuvance technologies for COVID-19 vaccine adjuvant

On Jan. 7, 2021, Oragenics announced entering into a material transfer agreement with Adjuvance Technologies for use of…

Read More Oragenics entered into material transfer agreement with adjuvance technologies for COVID-19 vaccine adjuvantContinue

Labcorp awarded CDC contract to study variants of COVID-19 virus and improve public health response
CDC | COVID-19 | Life Science History

Labcorp awarded CDC contract to study variants of COVID-19 virus and improve public health response

On Jan. 7, 2021, LabCorp announced that it had been awarded a contract from the Centers for Disease…

Read More Labcorp awarded CDC contract to study variants of COVID-19 virus and improve public health responseContinue

BioNTech published data on novel mRNA vaccine approach to treat autoimmune diseases in Science
Life Science History | Vaccine

BioNTech published data on novel mRNA vaccine approach to treat autoimmune diseases in Science

On Jan. 7, 2021, BioNTech announced publication of preclinical data on its novel mRNA vaccine approach against autoimmune…

Read More BioNTech published data on novel mRNA vaccine approach to treat autoimmune diseases in ScienceContinue

HHS announced $22 billion in funding to support expanded testing, vaccination distribution
CDC | COVID-19 | Life Science History

HHS announced $22 billion in funding to support expanded testing, vaccination distribution

On Jan. 6, 2021, the U.S. Department of Health and Human Services (HHS) announced the Centers for Disease…

Read More HHS announced $22 billion in funding to support expanded testing, vaccination distributionContinue

CureVac and Bayer joined forces on COVID-19 vaccine candidate CVnCoV
COVID-19 | Life Science History | Vaccine

CureVac and Bayer joined forces on COVID-19 vaccine candidate CVnCoV

On Jan. 6, 2021, Bayer announced it had signed a collaboration and services agreement with CureVac, a biopharmaceutical…

Read More CureVac and Bayer joined forces on COVID-19 vaccine candidate CVnCoVContinue

Large clinical trial tested combination monoclonal antibody therapy for mild/moderate COVID-19
COVID-19 | Life Science History

Large clinical trial tested combination monoclonal antibody therapy for mild/moderate COVID-19

On Jan. 5, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) announed that a phase 2/3…

Read More Large clinical trial tested combination monoclonal antibody therapy for mild/moderate COVID-19Continue

AIM ImmunoTech announced first COVID-19-induced chronic fatigue モLong Haulerヤ patient dosed with Ampligen
COVID-19 | Life Science History

AIM ImmunoTech announced first COVID-19-induced chronic fatigue モLong Haulerヤ patient dosed with Ampligen

On Jan. 5, 2021, AIM ImmunoTech announced that the active AMP-511 Expanded Access Program (EAP) had dosed its…

Read More AIM ImmunoTech announced first COVID-19-induced chronic fatigue モLong Haulerヤ patient dosed with AmpligenContinue

FDA announced statement on authorized dosing schedules for COVID-19 vaccines
COVID-19 | FDA | Life Science History

FDA announced statement on authorized dosing schedules for COVID-19 vaccines

On Jan. 4, 2021, the FDA announced that the two different mRNA vaccines were shown remarkable effectiveness of…

Read More FDA announced statement on authorized dosing schedules for COVID-19 vaccinesContinue

Audrey Winkelsas researched SMA through the NIH Oxford-Cambridge Scholars Program
Life Science History | NIH

Audrey Winkelsas researched SMA through the NIH Oxford-Cambridge Scholars Program

On Jan. 4, 2021, Audrey Winkelsas, a 2015 NIH Oxford-Cambridge Scholars Program doctoral student with spinal muscle atrophy…

Read More Audrey Winkelsas researched SMA through the NIH Oxford-Cambridge Scholars ProgramContinue

Theophrastus wrote of Greeks rotating their staple crops to enhance soil fertility
Agriculture | Life Science History | Prehistory

Theophrastus wrote of Greeks rotating their staple crops to enhance soil fertility

Greek philosopher Theophrastus (371-287 BCE), the “Father of Botany” wrote of Greeks rotating their staple crops with broad…

Read More Theophrastus wrote of Greeks rotating their staple crops to enhance soil fertilityContinue

Bausch Health’s DEXAVEN received new indication in Poland to treat patients with SARS-CoV-2
COVID-19 | Life Science History

Bausch Health’s DEXAVEN received new indication in Poland to treat patients with SARS-CoV-2

On Dec. 30, 2020, Bausch Health announced that the Office for Registration of Medicinal Products, Medical Devices and…

Read More Bausch Health’s DEXAVEN received new indication in Poland to treat patients with SARS-CoV-2Continue

NIH study uncovered blood vessel damage and inflammation in COVID-19 patientsメ brains but no infection
COVID-19 | Life Science History | NIH

NIH study uncovered blood vessel damage and inflammation in COVID-19 patientsメ brains but no infection

On Dec. 30, 2020, the NIH researchers announced that an in-depth study of how COVID-19 affects a patientメs…

Read More NIH study uncovered blood vessel damage and inflammation in COVID-19 patientsメ brains but no infectionContinue

Page navigation

Previous PagePrevious 1 … 38 39 40 41 42 … 173 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search